Program News
News and stories about the UNC Lineberger Global Oncology Research Program
-
Lymphoma study shows increased malaria risk with rituximab treatment
Researchers with the UNC Institute for Global Health and Infectious Diseases, in collaboration with the UNC Lineberger and UNC Project-Malawi, found adults receiving rituximab as part of cancer treatment face a significantly higher risk of developing symptomatic malaria in an endemic region.
-
Damania and Dittmer honored with Battle Distinguished Cancer Research Award
Blossom Damania, PhD, and Dirk Dittmer, PhD, are being recognized individually for their expertise in cancer virology and global oncology, and their service to the university and state.
-
Alexander outlines efforts to develop pediatric cancer fellowship program in Ethiopia
Thomas Alexander, MD, MPH, and colleagues report on their work to help establish a pediatric hematology-oncology training curriculum in Ethiopia.
-
NCI grant funds UNC-led consortium studying HIV-related cancers in sub-Saharan Africa
A team of UNC researchers are partnering with colleagues at three institutions in Africa to study HIV-associated malignancies: Kaposi sarcoma, cervical cancer and lymphoma.
-
Researchers unveil experimental compound to block therapeutic target in blood cancer
Researchers at the UNC Lineberger Comprehensive Cancer Center have discovered a hyperactive cell signal that contributes to tumor growth in an aggressive blood cancer. They also developed an experimental therapeutic to block the signal and slow tumor growth. In the journal Proceedings of the National Academy of Sciences, the researchers reported they have identified a … Read more